Skip to content
Home / Companies / TNGX TNG
Tango Therapeutics, Inc. (TNGX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest TNGX Insider Trades
About Tango Therapeutics, Inc. (TNGX) Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Headquarters BOSTON, MA
Employees 137
Listed 2021
Exchange XNAS https://www.tangotx.com SEC filings for TNGX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 6 81,000 $2.15M Grant or award 10 132,790 Option exercise 6 162,000
TNGX Insider Transactions (Form 4) 70 33 Form 4 filings on record, the earliest from Oct 23, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 3, 2026 AC Adam Crystal - Officer Option exercise Common Stock 27,000
Recent TNGX Form 8-K Filings 5
Recent TNGX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 3, 2026 ADAM CRYSTAL Officer 81,000 $2.20M View on EDGAR Jun 17, 2026 - -
TNGX Insider Trading - FAQ
What is the latest insider trade for TNGX? Tango Therapeutics, Inc. (TNGX) had 8 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for TNGX runs to 33 Form 4 filings, the earliest from 2024-10-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying TNGX stock? No insider purchases of TNGX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling TNGX stock? 6 insider sales of TNGX were filed in the last 90 days, totaling $2.15M.
Where can I see TNGX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks TNGX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow TNGX insider buys? Create a free InsiderAlpha account and press Watch on this page to add TNGX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track TNGX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Open-market sale
$594K
Market cap $3.94B
P/E ratio -
Dividend yield -
Average volume 3.73M
52 week high $34.39
52 week low $6.25
Today's high $25.09
Today's low $23.28
Open $24.93
Volume 2.00M
Previous close $25.28
Shares outstanding 168.61M Market cap
$3.94B
137 employees
TNGX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 6 sales totaling $2.15M.
Most-Active TNGX Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 3, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 5,267 $26.79 $141K
Aug 3, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 21,733 $27.35 $594K
Aug 3, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 27,000 $0.00 -
Jul 1, 2026 AC Adam Crystal - Officer Option exercise Common Stock 27,000 $5.20 $140K
Jul 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 19,629 $29.34 $576K
Jul 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 7,371 $30.25 $223K
Jul 1, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 27,000 $0.00 -
Jun 19, 2026 RA Robert Azelby Grant or award Stock Option (Right to Buy) 35,910 $0.00 -
Jun 5, 2026 JK John B. Ketchum Grant or award Stock Option (Right to Buy) 25,000 $0.00 -
Jun 5, 2026 MR Mace Rothenberg Grant or award Stock Option (Right to Buy) 25,000 $0.00 -
Jun 5, 2026 SL Sung Lee Grant or award Common Stock 570 $0.00 -
Jun 5, 2026 SL Sung Lee Grant or award Stock Option (Right to Buy) 3,570 $0.00 -
Jun 1, 2026 AC Adam Crystal - Officer Option exercise Common Stock 27,000 $5.20 $140K
Jun 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 6,140 $22.25 $137K
Jun 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 20,860 $23.06 $481K
Jun 1, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 27,000 $0.00 -
May 1, 2026 AC Adam Crystal - Officer Option exercise Common Stock 27,000 $5.20 $140K
May 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 25,900 $21.19 $549K
May 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 1,100 $22.00 $24K
May 1, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 27,000 $0.00 -
May 1, 2026 MG Matthew Gall - Officer Grant or award Common Stock 40,000 $0.00 -
May 1, 2026 MG Matthew Gall - Officer Grant or award Stock Option (Right to Buy) 240,000 $0.00 -
Apr 29, 2026 SL Sung Lee Grant or award Common Stock 12,300 $0.00 -
Apr 29, 2026 SL Sung Lee Grant or award Stock Option (Right to Buy) 5,200 $0.00 -
Apr 15, 2026 AC Adam Crystal - Officer Option exercise Common Stock 38,460 $5.20 $200K
Apr 15, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 38,460 $25.00 $962K
Apr 15, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 38,460 $0.00 -
Apr 1, 2026 AC Adam Crystal - Officer Option exercise Common Stock 27,000 $5.20 $140K
Apr 1, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 27,000 $21.20 $572K
Apr 1, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 27,000 $0.00 -
Mar 25, 2026 AC Adam Crystal - Officer Option exercise Common Stock 12,000 $5.20 $62K
Mar 25, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 12,000 $20.11 $241K
Mar 25, 2026 AC Adam Crystal - Officer Option exercise Stock Option (Right to Buy) 12,000 $0.00 -
Mar 5, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 20,251 $15.00 $304K
Feb 25, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 54,345 $12.77 $694K
Feb 3, 2026 DB Daniella Beckman - Officer Open-market sale Common Stock 10,204 $12.26 $125K
Feb 2, 2026 DB Daniella Beckman - Officer Grant or award Stock Option (Right to Buy) 265,980 $0.00 -
Feb 2, 2026 BW Barbara Weber - Officer Grant or award Common Stock 37,522 $0.00 -
Feb 3, 2026 BW Barbara Weber - Officer Open-market sale Common Stock 30,186 $12.26 $370K
Feb 3, 2026 BW Barbara Weber - Officer Open-market sale Common Stock 333 $12.90 $4K
Feb 2, 2026 BW Barbara Weber - Officer Grant or award Stock Option (Right to Buy) 222,132 $0.00 -
Feb 2, 2026 AC Adam Crystal - Officer Grant or award Common Stock 47,460 $0.00 -
Feb 3, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 18,251 $12.26 $224K
Feb 3, 2026 AC Adam Crystal - Officer Open-market sale Common Stock 201 $12.90 $3K
Feb 2, 2026 AC Adam Crystal - Officer Grant or award Stock Option (Right to Buy) 284,760 $0.00 -
Jan 8, 2026 MP Malte Peters - Officer Grant or award Common Stock 350,000 $0.00 -
Jan 8, 2026 MP Malte Peters - Officer Grant or award Stock Option (Right to Buy) 1,650,000 $0.00 -
Jan 2, 2026 SL Sung Lee Grant or award Common Stock 10,000 $0.00 -
Jan 2, 2026 SL Sung Lee Grant or award Stock Option (Right to Buy) 60,000 $0.00 -
Nov 3, 2025 MP Malte Peters Grant or award Stock Option (Right to Buy) 150,000 $0.00 -
Nov 14, 2024 MR Mace Rothenberg Open-market purchase Common Stock 10,000 $3.62 $36K
Nov 18, 2024 MR Mace Rothenberg Open-market purchase Common Stock 10,000 $3.78 $38K
TRM $CORT
CORCEPT THERAPEUTICS INC
